Cargando…
Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
Autores principales: | Anguiano-Álvarez, Víctor Manuel, Maza-Larrea, José Antonio, Rosado-Hernández, Francisco Javier, Rojas-Velasco, Gustavo, Izaguirre-Ávila, Raúl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478626/ https://www.ncbi.nlm.nih.gov/pubmed/34400588 http://dx.doi.org/10.5045/br.2021.2020245 |
Ejemplares similares
-
Ruxolitinib: Extreme thrombocytosis: case report
Publicado: (2021) -
Extreme thrombocytosis in a traumatic patient
por: Kim, Hyun-Hea, et al.
Publicado: (2013) -
Anesthesia for a patient with thrombocytosis
por: Bharath Kumar, TV, et al.
Publicado: (2013) -
Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
por: Torres-Machorro, Adriana, et al.
Publicado: (2020) -
A Novel Case of Extreme Thrombocytosis in Acute Myeloid Leukemia Associated With Isochromosome 17q and Copy Neutral Loss of Heterozygosity
por: You, Eunkyoung, et al.
Publicado: (2015)